Novartis Ag (NVS) Asset Utilization Ratio (2009 - 2010)
Novartis Ag (NVS) posted Asset Utilization Ratio of 0.23 for Q1 2010, down 100.0% sequentially from 232155.64 in Q4 2009, and down 100.0% YoY from 258492516920.0 in Q1 2009.
Novartis Ag (NVS) Asset Utilization Ratio (2009 - 2010) Analysis & Trends
Novartis Ag has reported Asset Utilization Ratio for 2 years, with the latest figure at 0.23 in Q1 2010.
- Quarterly Asset Utilization Ratio fell 100.0% year-over-year to 0.23 in Q1 2010, while the trailing twelve-month figure through Mar 2010 was 0.23 (down 100.0% YoY) and the FY2025 annual result came in at 0.51, up 2.78% from the prior year.
- Asset Utilization Ratio fell to 0.23 in Q1 2010 per NVS's latest filing, from 232155.64 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 258484297460.04 in Q1 2009 and troughed at 0.23 in Q1 2010.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.15 Bn | 634.39 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 469.47 Bn | 462.91 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 380.63 Bn | 373.49 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 302.58 Bn | 294.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.84 Bn | 252.94 Bn | 12.86 Bn | 0.53 |
| 6 | Amgen | 236.70 Bn | 222.71 Bn | 7.24 Bn | 0.40 |
| 7 | Gilead Sciences | 182.92 Bn | 179.74 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 161.16 Bn | 149.47 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 105.59 Bn | 101.42 Bn | 8.24 Bn | 0.64 |
| 10 | Sanofi | 54.99 Bn | 47.61 Bn | 10.79 Bn | 0.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2010 | 0.23 |
| Dec 31, 2009 | 232,155.64 |
| Sep 30, 2009 | 241.92 Bn |
| Jun 30, 2009 | 124.22 Bn |
| Mar 31, 2009 | 258.48 Bn |